EYPT
Eyepoint Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.08B
P/E Ratio
—
EPS
$-3.51
Beta
1.77
52W High
$19.11
52W Low
$5.57
50-Day MA
$13.46
200-Day MA
$13.97
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
6.16
PEG Ratio
—
About Eyepoint Pharmaceuticals Inc
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and markets ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company is headquartered in Watertown, Massachusetts.
Fundamentals
| Revenue (TTM) | $7.61M |
| Gross Profit (TTM) | $-224.75M |
| EBITDA | $-279.38M |
| Operating Margin | -450.70% |
| Return on Equity | -102.70% |
| Return on Assets | -54.10% |
| Revenue/Share (TTM) | $0.10 |
| Book Value | $0.40 |
| Price-to-Book | 4.70 |
| Price-to-Sales (TTM) | 142.38 |
| EV/Revenue | 115.81 |
| EV/EBITDA | 11.56 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 161.70% |
| Shares Outstanding | $83.84M |
| Float | $75.28M |
| % Insiders | 3.67% |
| % Institutions | 110.05% |
Historical Volatility
HV 10-Day
60.20%
HV 20-Day
50.10%
HV 30-Day
47.05%
HV 60-Day
56.84%
HV Rank
7.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($37.00 target)
3
Strong Buy10
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026